Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
This comparison highlights the pros and cons of total market and total world retirement strategies to help you decide which better fits your retirement plan.
28,570 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Looking to ride a big move in a small-cap space? Learn how to spot a small-cap growth stock before it hits its next e...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
A high-profile sale sparks a crypto market reshuffle. This morning minute breaks down what Saylor's move means for Bi...
LNG players like Cheniere Energy have big moves ahead as expansion trains boost export capacity. This article breaks ...
A sharp 87% drop in February crypto losses belies a pivot by attackers toward social engineering and user-targeted sc...
FEZ investors see lumpy payouts tied to eurozone dividend calendars. This piece breaks down what that means for incom...
Ares Capital has long dazzled income investors with a high dividend yield. After a challenging quarter, the question ...
U.S. equities extended gains as investors digested a leadership shift at the Federal Reserve and a cautious path for ...
As AI expands, data-center construction flourishes. This piece explains why sterling infrastructure should regain mom...
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
ANI Pharma's Q4 2025 results set the stage for the pharma space. This guide breaks down what the numbers mean for the...